Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wikstrand

Showing results (241-250 of 277) with videos related to

Pageof 28
Sort By:
Cancer Research|February 1, 1988
Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft modelY S Lee, D E Bullard, M R Zalutsky, et al.
Acta Cytologica|November 1, 1987
The use of a panel of monoclonal antibodies in the evaluation of cytologic specimens from the central nervous systemW W Vick, C J Wikstrand, D E Bullard, et al.
British Journal of Cancer|February 1, 1985
A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomasD E Bullard, D G Thomas, J L Darling, et al.
Leukemia & Lymphoma|October 1, 2005
Tenascin and microvessel stromal changes in patients with non-Hodgkin's lymphoma are isolated to the sites of disease and vary in correlation to disease activityDavid A Rizzieri, Martha Wadleigh, Carol J Wikstrand, et al.
Acta Neuropathologica|January 1, 1991
Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomasD C Longee, C J Wikstrand, J E Månsson, et al.
Acta Cytologica|September 1, 1992
Application of a panel of antiganglioside monoclonal antibodies to cytologic specimensW W Vick, J W Tello, C J Wikstrand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiformeChien-Tsun Kuan, Kenji Wakiya, Jeannette M Dowell, et al.
Genome Research|September 14, 2000
Identifying potential tumor markers and antigens by database mining and rapid expression screeningW T Loging, A Lal, I M Siu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumorsAmy B Heimberger, Laura E Crotty, Gary E Archer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiformeChris A Learn, Tristan L Hartzell, Carol J Wikstrand, et al.
Pageof 28

Showing results (241-250 of 277) with videos related to

Sort By:
Pageof 28
Cancer Research|February 1, 1988
Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft modelY S Lee, D E Bullard, M R Zalutsky, et al.
Acta Cytologica|November 1, 1987
The use of a panel of monoclonal antibodies in the evaluation of cytologic specimens from the central nervous systemW W Vick, C J Wikstrand, D E Bullard, et al.
British Journal of Cancer|February 1, 1985
A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomasD E Bullard, D G Thomas, J L Darling, et al.
Leukemia & Lymphoma|October 1, 2005
Tenascin and microvessel stromal changes in patients with non-Hodgkin's lymphoma are isolated to the sites of disease and vary in correlation to disease activityDavid A Rizzieri, Martha Wadleigh, Carol J Wikstrand, et al.
Acta Neuropathologica|January 1, 1991
Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomasD C Longee, C J Wikstrand, J E Månsson, et al.
Acta Cytologica|September 1, 1992
Application of a panel of antiganglioside monoclonal antibodies to cytologic specimensW W Vick, J W Tello, C J Wikstrand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiformeChien-Tsun Kuan, Kenji Wakiya, Jeannette M Dowell, et al.
Genome Research|September 14, 2000
Identifying potential tumor markers and antigens by database mining and rapid expression screeningW T Loging, A Lal, I M Siu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumorsAmy B Heimberger, Laura E Crotty, Gary E Archer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiformeChris A Learn, Tristan L Hartzell, Carol J Wikstrand, et al.
Pageof 28